Literature DB >> 1694777

Histamine H3 receptor binding sites in rat brain membranes: modulations by guanine nucleotides and divalent cations.

J M Arrang1, J Roy, J L Morgat, W Schunack, J C Schwartz.   

Abstract

The binding of [3H](R)alpha-methylhistamine, a potent and specific agonist at histamine H3 receptors, was investigated with membranes of rat cerebral cortex. In phosphate buffer the specific binding defined with thioperamide, an H3 receptor antagonist, displayed characters of reversibility and saturability with a Bmax of approximately 30 fmol/mg protein. The KD, derived from either dissociation/association rates or saturation kinetics at equilibrium, was approximately 0.5 nM at 25 degrees C. Competition studies indicated that the binding occurred with a stereoselectivity and pharmacological specificity similar to that of functional H3 autoreceptors regulating histamine release in brain slices. However, whereas the potency of antagonists was closely similar in the two assay systems, that of agonists was approximately 10-fold higher in the binding assay. Among antagonists burimamide was the only one to compete with a pseudo-Hill coefficient significantly different from unity (nH = 0.48 +/- 0.03), indicating a possible heterogeneity among binding sites. The presence of 2.6 mM Ca2+, in a modified Krebs-Ringer medium, promoted the conversion of a larger fraction of sites into a low-affinity component with a KD of 16 nM. The presence of guanylnucleotides in the Krebs-Ringer medium with Ca2+ abolished the binding to this low-affinity component whereas in a phosphate buffer only the KD was slightly increased. It is concluded that the H3 receptor, like many other amine receptors, is coupled to its still unidentified effector system via a G-protein and regulated by Ca2+. However, unlike the latter, the H3 receptor is down-regulated by the divalent cation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694777     DOI: 10.1016/0922-4106(90)90005-i

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  19 in total

1.  Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand.

Authors:  David G Witte; Betty Bei Yao; Thomas R Miller; Tracy L Carr; Steven Cassar; Rahul Sharma; Ramin Faghih; Bruce W Surber; Timothy A Esbenshade; Arthur A Hancock; Kathleen M Krueger
Journal:  Br J Pharmacol       Date:  2006-05-22       Impact factor: 8.739

2.  Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.

Authors:  Florence Gbahou; Ludwig Vincent; Marie Humbert-Claude; Joel Tardivel-Lacombe; Claude Chabret; Jean-Michel Arrang
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

Review 3.  The histamine H3 receptor: from discovery to clinical trials with pitolisant.

Authors:  Jean-Charles Schwartz
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

Review 4.  An update on histamine H3 receptors and gastrointestinal functions.

Authors:  G Bertaccini; G Coruzzi
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

5.  Histaminergic modulation of GABAergic transmission in rat ventromedial hypothalamic neurones.

Authors:  I S Jang; J S Rhee; T Watanabe; N Akaike; N Akaike
Journal:  J Physiol       Date:  2001-08-01       Impact factor: 5.182

6.  [3H]-thioperamide as a radioligand for the histamine H3 receptor in rat cerebral cortex.

Authors:  A Alves-Rodrigues; R Leurs; T S Wu; G D Prell; C Foged; H Timmerman
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

7.  Effects of histamine H(3) receptor activation on the behavioral-stimulant effects of methamphetamine and cocaine in mice and squirrel monkeys.

Authors:  Matthew L Banks; Daniel F Manvich; Rayna M Bauzo; Leonard L Howell
Journal:  Pharmacology       Date:  2009-01-15       Impact factor: 2.547

8.  Histamine H3A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex.

Authors:  E Schlicker; A Behling; G Lümmen; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

9.  H3 receptor-mediated inhibition of noradrenaline release: an investigation into the involvement of Ca2+ and K+ ions, G protein and adenylate cyclase.

Authors:  E Schlicker; M Kathmann; M Detzner; H J Exner; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-07       Impact factor: 3.000

10.  Characterization of histamine H3 receptors regulating acetylcholine release in rat entorhinal cortex.

Authors:  J M Arrang; G Drutel; J C Schwartz
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.